Google
English
French
German
Italian
Japanese
Portuguese
SpanishTrusted Resources: News & Meetings
Latest announcements and gatherings
Amyloidosis Support Groups Webinar on ATTRv and ATTRwt Amyloidosis
Please join us on January 21st, 2023 from 12:00 pm – 3:00 pm ET for our next webinar on ATTRv and ATTRwt Amyloidosis. Our speakers include Cardiologist Mathew Maurer, MD, Columbia University; Neurologist Chafic Karam, MD, University of Pennsylvania, and Pharmaceutical Representatives who will be discussing the treatments and clinical trials for ATTR.
Have a question for the doctors? Email it IN ADVANCE to info@amyloidosissupport.org.
This event has ended.
myBinderRelated Content
-
Managing hATTR Amyloidosishttps://www.youtube.com/watch?v=mlEYOijR...
-
What Do All These Neurological Tests Mean? – ASG Webinar 6/7https://www.youtube.com/watch?v=IzC_yaqs...
-
Transthyretin Cardiac Amyloidosis in Older AmericansWild-type transthyretin cardiac amyloido...
-
Tips for Managing Your Professional Life With hATTR AmyloidosisTelling your employer about your hATTR a...
-
Eidos Clinical Trial Update – ASG Webinar 5/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Q&A Discussion on Attralus Trials and Diflunisal Use – ASG Webinar 7.15.23 – 7/7https://www.youtube.com/watch?v=UcxmPgZ7...
-
New Era of Medicine: Researchers Publish First Positive Clinical Data for In Vivo Genome Editing in HumansResearchers from Intellia Therapeutics, ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
